treatment-vs-dmso-directional-de-pathway-analysis.html

syn64768955

Created By Sasha Scott Sasha.scott

studyId: syn53604892
studyName: Advancing RAS pathway targeted therapy in NF1-MPNST - effects of SHP2 and CDK4 or CDK6 inhibitors on the tumor and the tumor immune microenvironment
accessType: Private
initiative: Other
fundingAgency: Other

treatment-vs-dmso-directional-de-pathway-analysis.html page is loading…